In September 2013, the FDA introduced new labeling suggestions for extended performing and extended launch opioids necessitating companies to eliminate average pain as indication for use, in its place stating the drug is for "ache severe enough to call for day-to-day, about-the-clock, long lasting opioid procedure".Oxycodone is useful for running a